I didn't understand your reply to flipper. There is a huge unknown hanging out there, namely the reason for the enrollment halt. The short thesis is that anything not explained should certainly be a big red flag to investors if not definite proof of problems that the company refuses to discuss because they are indeed problems. Longs are making a very big bet against that very commonsensical view, based on faith that LG and LP have not been lying to shareholders when they have given certain reassurances that e.g. they have been working closely with the FDA with great cooperation, and that they believe that the treatment will be approved, in spite of whatever the issue was that led to the enrollment hold. Knowing with certainty about all of that from being directly involved with the FDA discussions from the FDA or from the company side, or having one's spouse in that position, could probably be taken as beyond a reasonable doubt, having inside information, if one traded on it. Surely you don't disagree with that do you?
News 
Market Data 
Discover 
